AHA #HealthCareInnovation blog: Tools to address the opioid crisis
Although COVID-19 has been a significant contributor to the substance abuse epidemic, it does not explain the large number of drug overdose deaths between May 2019 and May 2020 — the most ever recorded in a 12-month period, writes Holly Geyer, M.D., hospital internal medicine practitioner at Mayo Clinic in Phoenix.
Geyer discusses opioid stewardship programs and how the AHA’s Stem the Tide curriculum can provide guidance. Read more.
Related News Articles
Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…
Headline
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to…
Headline
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and…
Headline
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…
Headline
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and…